此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Retinal Capillary Vessel Density and Foveal Avascular Zone Size in Patients With Psoriatic Arthritis: A Case-Control Study. (PsA-RETINA)

2026年10月7日 更新者:Koray Ayar、Bursa Yuksek Ihtisas Training and Research Hospital

Evaluation of Retinal Capillary Vascular Structures and the Foveal Avascular Zone in Patients With Psoriatic Arthritis.

In terms of blood flow per unit of tissue, the retina is one of the tissues with the highest blood flow in the body. Parameters such as the thickness of the choroid layer, which plays a crucial role in maintaining normal eye function, the dimensions of the foveal avascular zone (FAZ) supplied by this layer, and retinal vascular networks can be measured using non-invasive methods. OCTA (Optical Coherence Tomography Angiography) is an imaging tool that enables the non-invasive assessment of retinal microvascular densities and the measurement of the foveal avascular zone's dimensions. Studies conducted to date indicate that retinal capillary vessels and the dimensions of the foveal avascular zone are affected in rheumatological diseases, especially associated with systemic inflammation. This study aims to compare retinal capillary vessel density and foveal avascular zone dimensions in patients with psoriatic arthritis against those in a healthy population and in patients with psoriasis who do not have psoriatic arthritis, utilizing the non-invasive method of optical coherence tomography angiography.

研究概览

详细说明

In terms of blood flow per unit of tissue, the retina is one of the tissues with the highest blood flow in the body. Non-invasive methods allow for the measurement of-and the detection of changes in-the thickness of the choroid layer (which plays a crucial role in maintaining normal eye function), the foveal avascular zone (nourished by this layer), and the retinal vascular networks. OCTA (Optical Coherence Tomography Angiography) is an imaging tool capable of non-invasively assessing retinal microvascular densities and measuring the dimensions of the foveal avascular zone. Retinal microvascular structures can be affected by systemic pathologies, including various eye diseases. In recent years, there has been growing evidence indicating that retinal vessel densities-as detected by OCTA-are significantly altered and the dimensions of the foveal avascular zone differ in patients with connective tissue diseases, vasculitis, and spondylitis. Psoriatic arthritis is a common chronic inflammatory disease characterized by both spondyloarthropathy and peripheral arthritis involvement. There is currently no data in the literature regarding the status of the choroidal vasculature-a highly perfused tissue-in patients with psoriatic arthritis or its relationship with disease activity. In this study, we aimed to compare retinal capillary density and foveal avascular zone dimensions among patients with psoriatic arthritis, patients with psoriasis, and healthy individuals using OCTA. The study will also compare findings between subgroups of psoriatic patients with and without concomitant spondylitis.

研究类型

观察性的

注册 (估计的)

135

联系人和位置

本节提供了进行研究的人员的详细联系信息,以及有关进行该研究的地点的信息。

学习联系方式

  • 姓名:Koray Ayar, Associated Proffessor
  • 电话号码:1648 +90 224-2955000
  • 邮箱:ayarkoray@hotmail.com

学习地点

    • Yıldırım
      • Bursa、Yıldırım、土耳其(türkiye)、16130
        • 招聘中
        • University of Health Sciences, Bursa Yuksek Ihtisas Training and Research Hospital
        • 接触:
        • 接触:
          • Koray Ayar, Associated Proffessor (Dr.)
          • 电话号码:1648 +90 224-2955000
          • 邮箱:ayarkoray@hotmail.com
        • 首席研究员:
          • Koray Ayar, Associated Proffessor (Dr.)
        • 副研究员:
          • Neslihan Parmak Yener, Associated Proffessor

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 至 75年 (成人、年长者)

接受健康志愿者

是的

有资格学习的性别

全部

取样方法

非概率样本

研究人群

The study population consists of volunteers from among patients with psoriatic arthritis who are being followed at the study center's rheumatology clinic. The patient control group comprises volunteers diagnosed with psoriasis by a specialist dermatologist. Participants in the healthy control group are healthcare workers or patient companions matched for age and gender with the patient group and the patient control group.

描述

Inclusion Criteria:

  • Volunteers diagnosed with psoriatic arthritis according to CASPAR criteria
  • Volunteers diagnosed with psoriasis by a specialist dermatologist
  • Hospital staff or patient companions with no chronic illnesses

Exclusion Criteria:

  • Diabetes mellitus
  • Cancer
  • Pregnancy or lactation
  • Chronic renal failure
  • Glocome
  • History of eye surgery
  • History of eye trauma

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:CASE_CONTROL
  • 时间观点:PROSPECTIVE

队列和干预

团体/队列
干预/治疗
Psoriatic arthritis

Participants with psoriatic arthritis

Vessel density of retinal superficial capillary plexus

Vessel density of retinal deep capillary plexus

Vessel density of retinal prepapillary capillaries

FAZ essessment parameters

Psoriasis

Psoriasis participants with no other known systemic inflammatory disease

Vessel density of retinal superficial capillary plexus

Vessel density of retinal deep capillary plexus

Vessel density of retinal prepapillary capillaries

FAZ essessment parameters

Healthy controls

Patient companions or hospital staff with no known chronic illnesses

Vessel density of retinal superficial capillary plexus

Vessel density of retinal deep capillary plexus

Vessel density of retinal prepapillary capillaries

FAZ essessment parameters

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Retinal SCP, VD
大体时间:1 day

Vessel density of retinal superficial capillary plexus

1 day
Retinal DCP, VD
大体时间:1 day

Vessel density of retinal deep capillary plexus

1 day
Retinal RCP, VD
大体时间:1 day

Vessel density of retinal prepapillary capillaries

1 day
FAZ parameters
大体时间:1 day

Foveal avasculary assessment parameters

1 day

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (实际的)

2026年9月1日

初级完成 (估计的)

2027年8月20日

研究完成 (估计的)

2027年8月31日

研究注册日期

首次提交

2026年9月29日

首先提交符合 QC 标准的

2026年9月29日

首次发布 (实际的)

2026年10月5日

研究记录更新

最后更新发布 (实际的)

2026年10月13日

上次提交的符合 QC 标准的更新

2026年10月7日

最后验证

2026年9月1日

更多信息

与本研究相关的术语

计划个人参与者数据 (IPD)

计划共享个人参与者数据 (IPD)?

不

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅